Real-time imaging of interactions of neutrophils with Cryptococcus neoformans demonstrates a crucial role of complement C5a-C5aR signaling

Infection and Immunity

Volumn 84, Issue 1, 2015, Pages 216-229

  Sun, Donglei ^a   Zhang, Mingshun ^a,b   Liu, Gongguan ^a   Wu, Hui ^a,c   Zhu, Xiaoping ^a   Zhou, Hong ^b   Shi, Meiqing ^a  

^a UNIVERSITY OF MARYLAND   (United States)

^b NANJING MEDICAL UNIVERSITY   (China)

^c NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD16 ANTIGEN; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C3B; COMPLEMENT COMPONENT C3B RECEPTOR; COMPLEMENT COMPONENT C5; COMPLEMENT COMPONENT C5A; COMPLEMENT COMPONENT C5A RECEPTOR; CYTOCHALASIN D; MITOGEN ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; C5AR1 PROTEIN, HUMAN; COMPLEMENT C3A RECEPTOR; COMPLEMENT RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE P38;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIFUNGAL ACTIVITY; ARTICLE; CELL ADHESION; CELL FUNCTION; CELL LEVEL; CELL MIGRATION; CELL MOTION; CELL STIMULATION; CELL SURVIVAL; COLONY FORMING UNIT; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; ENZYME ACTIVATION; ENZYME INHIBITION; FUNGAL STRAIN; IN VITRO STUDY; LEUKOCYTE ACTIVATION; MOLECULAR DYNAMICS; MOLECULAR IMAGING; MOLECULAR INTERACTION; MOUSE; NEUTROPHIL; NONHUMAN; PATHOGEN CLEARANCE; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN SECRETION; SIGNAL TRANSDUCTION; SURFACE PROPERTY; UPREGULATION; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; C57BL MOUSE; CELL CULTURE; CRYPTOCOCCOSIS; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; MENINGOENCEPHALITIS; METABOLISM; MICROBIOLOGY;

ANIMALS; ANTIGENS, CD11B; CELL MOVEMENT; CELLS, CULTURED; COMPLEMENT C3; COMPLEMENT C5A; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; MENINGOENCEPHALITIS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUTROPHILS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHAGOCYTOSIS; RECEPTOR, ANAPHYLATOXIN C5A; RECEPTORS, COMPLEMENT; SIGNAL TRANSDUCTION;

EID: 84957716220     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01197-15     Document Type: Article

References (50)

1. Diamond RD, Root RK, Bennett JE. 1972. Factors influencing killing of Cryptococcus neoformans by human leukocytes in vitro. J Infect Dis 125: 367-376. http://dx.doi.org/10.1093/infdis/125.4.367.
2. Kozel TR, Highison B, Stratton CJ. 1984. Localization on encapsulated Cryptococcus neoformans of serum components opsonic for phagocytosis by macrophages and neutrophils. Infect Immun 43:574-579.
3. Voelz K, May RC. 2010. Cryptococcal interactions with the host immune system. Eukaryot Cell 9:835-846. http://dx.doi.org/10.1128/EC.00039-10.
4. Zhang M, Sun D, Shi M. 2015. Dancing cheek to cheek: Cryptococcus neoformans and phagocytes. Springer Plus 4:410. http://dx.doi.org/10.1186/s40064-015-1192-3.
5. Miller MF, Mitchell TG. 1991. Killing of Cryptococcus neoformans strains by human neutrophils and monocytes. Infect Immun 59:24-28.
6. Qureshi A, Subathra M, Grey A, Schey K, Del Poeta M, Luberto C. 2010 Role of sphingomyelin synthase in controlling the antimicrobial activity of neutrophils against Cryptococcus neoformans. PLoS One 5:e15587. http://dx.doi.org/10.1371/journal.pone.0015587.
7. Qureshi A, Grey A, Rose KL, Schey KL, Del Poeta M. 2011. Cryptococcus neoformans modulates extracellular killing by neutrophils. Front Microbiol 2:193. http://dx.doi.org/10.3389/fmicb.2011.00193.
8. Rocha JD, Nascimento MT, Decote-Ricardo D, Corte-Real S, Morrot A, Heise N, Nunes MP, Previato JO, Mendonca-Previato L, Dos Reis GA, Saraiva EM, Freire-de-Lima CG. 2015. Capsular polysaccharides from Cryptococcus neoformans modulate production of neutrophil extracellular traps (NETs) by human neutrophils. Sci Rep 5:8008. http://dx.doi.org/10.1038/srep08008.
9. Chaturvedi V, Wong B, Newman SL. 1996. Oxidative killing of Cryptococcus neoformans by human neutrophils. Evidence that fungal mannitol protects by scavenging reactive oxygen intermediates. J Immunol 156: 3836-3840.
10. Tacker JR, Farhi F, Bulmer GS. 1972. Intracellular fate of Cryptococcus neoformans. Infect Immun 6:162-167.
11. Mambula SS, Simons ER, Hastey R, Selsted ME, Levitz SM. 2000. Human neutrophil-mediated nonoxidative antifungal activity against Cryptococcus neoformans. Infect Immun 68:6257-6264. http://dx.doi.org/10.1128/IAI.68.11.6257-6264.2000.
12. Aratani Y, Kura F, Watanabe H, Akagawa H, Takano Y, Ishida-Okawara A, Suzuki K, Maeda N, Koyama H. 2006. Contribution of the myeloperoxidase-dependent oxidative system to host defence against Cryptococcus neoformans. J Med Microbiol 55:1291-1299. http://dx.doi.org/10.1099/jmm.0.46620-0.
13. Graybill JR, Bocanegra R, Lambros C, Luther MF. 1997. Granulocyte colony stimulating factor therapy of experimental cryptococcal meningitis. J Med Vet Mycol 35:243-247. http://dx.doi.org/10.1080/02681219780001221.
14. Klebanoff SJ. 2005. Myeloperoxidase: friend and foe. J Leukoc Biol 77: 598-625. http://dx.doi.org/10.1189/jlb.1204697.
15. Coffey MJ, Phare SM, George S, Peters-Golden M, Kazanjian PH. 1998. Granulocyte colony-stimulating factor administration to HIV-infected subjects augments reduced leukotriene synthesis and anticryptococcal activity in neutrophils. J Clin Invest 102:663-670. http://dx.doi.org/10.1172/JCI2117.
16. Vecchiarelli A, Monari C, Baldelli F, Pietrella D, Retini C, Tascini C, Francisci D, Bistoni F. 1995. Beneficial effect of recombinant human granulocyte colony-stimulating factor on fungicidal activity of polymorphonuclear leukocytes from patients with AIDS. J Infect Dis 171:1448-1454 http://dx.doi.org/10.1093/infdis/171.6.1448.
17. Wozniak KL, Kolls JK, Wormley FL, Jr. 2012. Depletion of neutrophils in a protective model of pulmonary cryptococcosis results in increased IL-17A production by gammadelta T cells. BMC Immunol 13:65. http://dx.doi.org/10.1186/1471-2172-13-65.
18. Mednick AJ, Feldmesser M, Rivera J, Casadevall A. 2003. Neutropenia alters lung cytokine production in mice and reduces their susceptibility to pulmonary cryptococcosis. Eur J Immunol 33:1744-1753. http://dx.doi.org/10.1002/eji.200323626.
19. Feldmesser M, Kress Y, Novikoff P, Casadevall A. 2000. Cryptococcus neoformans is a facultative intracellular pathogen in murine pulmonary infection. Infect Immun 68:4225-4237. http://dx.doi.org/10.1128/IAI.68.7.4225-4237.2000.
20. Zhang M, Sun D, Liu G, Wu H, Zhou H, Shi M. 1 October 2015. Real-time in vivo imaging reveals the ability of neutrophils to remove Cryptococcus neoformans directly from the brain vasculature. J Leukoc Biol http://dx.doi.org/10.1189/jlb.4AB0715-281R.
21. Diamond RD, May JE, Kane MA, Frank MM, Bennett JE. 1974. The role of the classical and alternate complement pathways in host defenses against Cryptococcus neoformans infection. J Immunol 112:2260-2270.
22. Kozel TR, Pfrommer GS. 1986. Activation of the complement system by Cryptococcus neoformans leads to binding of iC3b to the yeast. Infect Immun 52:1-5.
23. Diamond RD, May JE, Kane M, Frank MM, Bennett JE. 1973. The role of late complement components and the alternate complement pathway in experimental cryptococcosis. Proc Soc Exp BiolMed144:312-315. http://dx.doi.org/10.3181/00379727-144-37580.
24. Lovchik JA, Lipscomb MF. 1993. Role for C5 and neutrophils in the pulmonary intravascular clearance of circulating Cryptococcus neoformans. Am J Respir Cell Mol Biol 9:617-627. http://dx.doi.org/10.1165/ajrcmb/9.6.617.
25. Rhodes JC, Wicker LS, Urba WJ. 1980. Genetic control of susceptibility to Cryptococcus neoformans in mice. Infect Immun 29:494-499.
26. Shapiro S, Beenhouwer DO, Feldmesser M, Taborda C, Carroll MC, Casadevall A, Scharff MD. 2002. Immunoglobulin G monoclonal antibodies to Cryptococcus neoformans protect mice deficient in complement component C3. Infect Immun 70:2598-2604. http://dx.doi.org/10.1128/IAI.70.5.2598-2604.2002.
27. Kolev M, Le Friec G, Kemper C. 2014. Complement-tapping into new sites and effector systems. Nat Rev Immunol 14:811-820. http://dx.doi.org/10.1038/nri3761.
28. Kozel TR, Pfrommer GS, Redelman D. 1987. Activated neutrophils exhibit enhanced phagocytosis of Cryptococcus neoformans opsonized with normal human serum. Clin Exp Immunol 70:238-246.
29. Voelz K, Johnston SA, Rutherford JC, May RC. 2010. Automated analysis of cryptococcal macrophage parasitism using GFP-tagged cryptococci. PLoS One 5:e15968. http://dx.doi.org/10.1371/journal.pone.0015968.
30. Boxio R, Bossenmeyer-Pourie C, Steinckwich N, Dournon C, Nusse O. 2004 Mouse bone marrow contains large numbers of functionally competent neutrophils. J Leukoc Biol 75:604-611. http://dx.doi.org/10.1189/jlb.0703340.
31. Kozel TR, Wilson MA, Pfrommer GS, Schlageter AM. 1989. Activation and binding of opsonic fragments of C3 on encapsulated Cryptococcus neoformans by using an alternative complement pathway reconstituted from six isolated proteins. Infect Immun 57:1922-1927.
32. Truelsen K, Young T, Kozel TR. 1992. In vivo complement activation and binding of C3 to encapsulated Cryptococcus neoformans. Infect Immun 60:3937-3939.
33. Zaragoza O, Taborda CP, Casadevall A. 2003. The efficacy of complement-mediated phagocytosis of Cryptococcus neoformans is dependent on the location of C3 in the polysaccharide capsule and involves both direct and indirect C3-mediated interactions. Eur J Immunol 33:1957-1967. http://dx.doi.org/10.1002/eji.200323848.
34. Hunniger K, Bieber K, Martin R, Lehnert T, Figge MT, Loffler J, Guo RF, Riedemann NC, Kurzai O. 2015. A second stimulus required for enhanced antifungal activity of human neutrophils in blood is provided by anaphylatoxin C5a. J Immunol 194:1199-1210. http://dx.doi.org/10.4049/jimmunol.1401845.
35. Mollnes TE, Brekke OL, Fung M, Fure H, Christiansen D, Bergseth G, Videm V, Lappegard KT, Kohl J, Lambris JD. 2002. Essential role of the C5a receptor in E coli-induced oxidative burst and phagocytosis revealed by a novel lepirudin-based human whole blood model of inflammation. Blood 100:1869-1877.
36. Cara DC, Kaur J, Forster M, McCafferty DM, Kubes P. 2001. Role of p38 mitogen-activated protein kinase in chemokine-induced emigration and chemotaxis in vivo. J Immunol 167:6552-6558. http://dx.doi.org/10.4049/jimmunol.167.11.6552.
37. Kim D, Haynes CL. 2013. The role of p38 MAPK in neutrophil functions: single cell chemotaxis and surface marker expression. Analyst 138:6826-6833 http://dx.doi.org/10.1039/c3an01076g.
38. Liu X, Ma B, Malik AB, Tang H, Yang T, Sun B, Wang G, Minshall RD, Li Y, Zhao Y, Ye RD, Xu J. 2012. Bidirectional regulation of neutrophil migration by mitogen-activated protein kinases. Nat Immunol 13:457-464 http://dx.doi.org/10.1038/ni.2258.
39. Vedder NB, Harlan JM. 1988. Increased surface expression of CD11b/CD18 (Mac-1) is not required for stimulated neutrophil adherence to cultured endothelium. J Clin Invest 81:676-682. http://dx.doi.org/10.1172/JCI113372.
40. Korchak HM, Eisenstat BA, Hoffstein ST, Dunham PB, Weissmann G. 1980 Anion channel blockers inhibit lysosomal enzyme secretion from human neutrophils without affecting generation of superoxide anion. Proc Natl Acad Sci U S A 77:2721-2725. http://dx.doi.org/10.1073/pnas.77.5.2721.
41. Smith RJ, Bowman BJ, Iden SS. 1984. Effects of an anion channel blocker, 4, 4'-diisothiocyano-2, 2'-disulfonic acid stilbene (DIDS), on human neutrophil function. Biochem Biophys Res Commun 120:964-972. http://dx.doi.org/10.1016/S0006-291X(84)80201-6.
42. Tauber AI, Goetzl EJ. 1981. Inhibition of complement-mediated functions of human neutrophils by impermeant stilbene disulfonic acids. J Immunol 126:1786-1789.
43. Kozel TR, Pfrommer GS, Guerlain AS, Highison BA, Highison GJ. 1988 Strain variation in phagocytosis of Cryptococcus neoformans: dissociation of susceptibility to phagocytosis from activation and binding of opsonic fragments of C3. Infect Immun 56:2794-2800.
44. Dong ZM, Murphy JW. 1997. Cryptococcal polysaccharides bind to CD18 on human neutrophils. Infect Immun 65:557-563.
45. Taborda CP, Casadevall A. 2002. CR3 (CD11b/CD18) and CR4 (CD11c/CD18) are involved in complement-independent antibody-mediated phagocytosis of Cryptococcus neoformans. Immunity 16:791-802. http://dx.doi.org/10.1016/S1074-7613(02)00328-X.
46. Diamond RD, Erickson NF, III. 1982. Chemotaxis of human neutrophils and monocytes induced by Cryptococcus neoformans. Infect Immun 38: 380-382.
47. Laxalt KA, Kozel TR. 1979. Chemotaxigenesis and activation of the alternative complement pathway by encapsulated and non-encapsulated Cryptococcus neoformans. Infect Immun 26:435-440.
48. Monari C, Kozel TR, Bistoni F, Vecchiarelli A. 2002. Modulation of C5aR expression on human neutrophils by encapsulated and acapsular Cryptococcus neoformans. Infect Immun 70:3363-3370. http://dx.doi.org/10.1128/IAI.70.7.3363-3370.2002.
49. Coenjaerts FE, Walenkamp AM, Mwinzi PN, Scharringa J, Dekker HA, van Strijp JA, Cherniak R, Hoepelman AI. 2001. Potent inhibition of neutrophil migration by cryptococcal mannoprotein-4-induced desensitization. J Immunol 167:3988-3995. http://dx.doi.org/10.4049/jimmunol.167.7.3988.
50. Roubey RA, Ross GD, Merrill JT, Walton F, Reed W, Winchester RJ, Buyon JP. 1991. Staurosporine inhibits neutrophil phagocytosis but not iC3b binding mediated by CR3 (CD11b/CD18). J Immunol 146:3557-3562.